Methods: the Hrqol in 75 obese subjects waiting for bariatric surgery was assessed by the generic 15d instrument. the resulting 15d profile and single index score were compared to those of a sample of age-and gender-standardized general population (n = 4955).
der Finnish circumstances the operated patient will incur less costs to the health-care system after a mean of 7 years (1).
Outcome analysis in bariatric surgery is complex. There are several different meaningful endpoints. Important outcome measurements include the improvement or resolvement of medical comorbid conditions caused by obesity, and the possible changes in quality of life. Interest in the measurement of health-related quality of life (HRQoL) has increased considerably in recent years. There are many reports on quality of life outcomes following surgery for severe obesity (2-7), but few explain why they have chosen the instrument used or define what they mean by «quality of life».
In this study, we compared the HRQoL of obese subjects scheduled for bariatric surgery with that of the general population, standardized for age-and gender distribution. The HRQoL was measured by the generic 15D instrument (8).
INTRODUCTION
Morbid obesity continues to threaten the general health of those affected. Demands for surgical interventions in the morbidly obese patients is increasing fast all over the world. In Finland, a comprehensive Health Technology Assessment of Bariatric Table 1 . Indications for surgery were those generally accepted (BMI > 35 with co-morbidity or BMI > 40).
GENERAL POPULATION SAMPLE
The HRQoL of patients was compared with that of the general population. The data for the general population came from the National Health 2000 Health Examination Survey, which covered a representative sample of the Finnish population aged 30 years and over (9). For this analysis those individuals were selected, who were in the age range of patients (n = 4955). The population sample was weighted to reflect the age-and gender distribution of the patients.
THE 15D INSTRUMENT
The 15D is a generic, comprehensive, 15-dimensional, standardized, self-administered measure of health-related quality of life (HRQoL) that can be used both as a profile and single index score measure. This instrument subscribes conceptually to the definition of health by the World Health Organisation (WHO) as being composed of physical, mental and social well-being. It includes the following 15 dimensions: breathing, mental function, speech (communication), vision, mobility, usual activities, vitality, hearing, eating, elimination, sleeping, distress, discomfort and symptoms, sexual activity, and depression. Each dimension is divided into 5 levels, by which more or less of the attribute is distinguished. The valuation system of the 15D is based on an application of the multi-attribute utility theory. A set of utility or preference weights, elicited from the general population through a 3-stage valuation procedure, is used to generate A) the level values for each dimension on a 0-1 scale and B) the 15D score, representing the overall HRQoL, on a 0-1 scale (1 = no problems on any dimension, i.e., 'full' HRQoL, 0 = being dead). The level values reflect the goodness of the levels relative to no problems on the dimension (value of 1) and to being dead (value of 0). From the mean level values a 15D profile is drawn for a group of subjects (8). A difference ≥ 0.03 in the total 15D score is considered clinically important. In all important properties (reliability, validity, sensitivity, discriminatory power, and responsiveness to change) the 15D compares at least equally with existing, generally used profile and single index score instruments (8, 10-13).
STATISTICAL ANALySES
The continuous variables are described as means ± SD. The difference between the groups in the mean 15D dimension level values and scores were tested using a two-tailed independent samples t-test. The few missing item of data on any dimension of the 15D questionnaire were replaced by predictions from regression models with the other dimensions and age as explanatory variables. To explore, to what extent the HRQoL in obese subjects is related to obesity itself and possibly to the associated co-morbidity, a regression model was run in the pooled patient-population data with the 15D as dependent variable and age, gender, BMI and group dummy (0 = population, 1 = patients) as explanatory variables. If the regression coefficients of BMI and group dummy are statistically significant, the coefficient of BMI indicates, to what extent HRQoL is affected by obesity itself and the coefficient of group dummy the extent, to which HRQoL is affected presumably by comorbidity associated with obesity, other things equal. A P < 0.05 was considered statistically significant.
RESULTS
The obese patients were significantly worse off than age-and gender-standardized general population on 11 of the 15 dimensions (Table 2, Fig. 1 ). The mean total 15D score among patients scheduled for bariatric surgery was 0.844, and that of age-and genderstandardized general population 0.934. The difference is statistically highly significant and clinically important ( Table 2) . All these differences suggest that these morbidly obese patients suffer from a very poor HRQoL (Table 2, Fig. 1 ). No significant difference in the 15D score between men (0.838) and women (0.845) on the waiting list for bariatric surgery could be seen.
The results of regression analysis (Table 3) suggest that with age, gender and group standardized, an increase of one BMI unit decreases the 15D score by -0.0016. Correspondingly, with age, gender and BMI standardized, belonging to the group of patients decreases the 15D score by -0.061. This decrease can presumably be attributed to the co-morbidity associated with obesity. 14 Figure 1 
DISCUSSION
A difference of about 0.03 in the 15D score is such that people can on average feel the difference (8). The difference in 15D score between patients and controls in this study was three times that, 0.090. We have previously shown that 15D score was much worse compared to the mean 15D score among 710 Finnish adult controls in the age group 40-49 years and significantly improved, but not completely restored even 28 months after laparoscopic gastric banding (14) . However, those findings have to be interpreted with caution since a more detailed comparison of the 15D profiles between patients and age-and gender-standardized controls was not done. That is why we now performed such a comparison of the HRQoL profiles at baseline and the results shown in this study confirm our previous findings (14) . Bariatric patients were significantly worse off than age-and gender-standardized general population on 11 of the 15 dimensions (Table 2 ). There were no significant differences on the dimensions of hearing, eating, speech or mental function. The fact that the patients were significantly worse off on the dimension of seeing may be explained by the higher prevalence of type 2 diabetes and its possible complications. According to Chang et al. (4) the higher the BMI, the worse is the HRQoL. Our results suggest the same. This together with obesity-associated co-morbidity may explain the highly significant difference in HR-QoL between patients and controls seen in this study (Table 3) . To put the mean 15D score of our bariatric patient in perspective, the mean score of women of about the same mean age before breast reduction was 0.838 (15) and that of women before hysterectomy for benign uterine or ovarian cause 0.91 (16) .
Many previous studies using different HRQoL instruments have shown impairment of HRQoL in patients seeking surgical treatment (2, 4-7, 17). As there still are doubts about the necessity of bariatric surgery among many health care professionals and decision makers in Finland, it is important to show the actual need for treatment. Surgery is, beyond any doubt, the only effective treatment for morbid obesity (18) and many studies have demonstrated that the HRQoL will improve significantly after surgical treatment (6, 7, 17, (19) (20) (21) . At least one study has demonstrated superior HRQoL improvements to conservative treatment even 10 years later (6). We are currently following our patients and measuring possible changes in HRQoL after bariatric surgery, and results will be published when more long term follow up has been completed.
The fact that more women seek surgical treatment may be explained by a greater impairment in HRQoL at baseline in women compared to men (22) , although no difference in the 15D scores between men and women on the waiting list for surgery could be shown in this study. However, we did not measure the HR-QoL among all patients seeking surgical treatment, only among those already accepted.
Very recently a comprehensive national assessment of the surgical treatment of morbid obesity was published in Finland (1), unfortunately only in Finnish. In accordance with the HTA Core Model developed in the EUnetHTA project (European network for Health Technology Assessment), surgery was assessed from nine perspectives, or domains: health problem and current use of technology; description and technical characteristics of technology; safety; clinical effectiveness; costs and economical evaluation; ethical analysis; organisational aspects; social aspects; and legal aspects. The results indicate that surgical treatment of patients who suffer from severe morbid obesity gives significant health benefits to patients and reduces the costs to the health care system. Weight-loss operations are still quite rare in Finland, compared with other industrial countries, and the regional availability of bariatric services is quite uneven. The Finnish national health insurance do not entirely cover bariatric surgery costs, but decision makers will now have to grapple with the challenge of drafting uniform criteria for access to treatment and an ethically sustainable national strategy for the treatment of obesity. As pointed out by Dixon et al. (23) , it is indeed time to set a standard of care.
We hope that this report, demonstrating the very poor HRQoL among morbidly obese patients compared to the age-and gender-standardized general population will add to the evidence of the need for increasing bariatric surgery services also in Finland. 
